High Levels of Toxic Chemicals Found in Disposable Puff E-Cigarettes

Aug.03.2022
High Levels of Toxic Chemicals Found in Disposable Puff E-Cigarettes
One-time use Puff e-cigarettes contain high levels of unknown chemicals and synthetic coolants that are toxic to human cells.

A picture of a disposable puff electronic cigarette from Talbot Lab at the University of California, Riverside. Electronic cigarettes (EC) contain nicotine, solvents, and flavored chemicals, and are particularly popular among young people. In 2020, the US Food and Drug Administration (FDA) banned flavored EC pods based on cartridges, but this ban did not extend to "disposable" flavored EC products, such as Puff EC. Unfortunately, the chemical composition and toxicity of the liquid in Puff ECs is largely unknown.


Researchers from the University of California Riverside and Portland State University have examined 16 disposable Puff devices to determine their flavor chemicals, synthetic cooling agents, and nicotine concentrations. One of the synthetic cooling agents tested is WS-23 which provides a cooling sensation.


A team used gas chromatography and mass spectrometry to identify 126 flavor chemicals in Puff EC liquid and tested their toxicity on human bronchial epithelial cells. They reported in the journal Toxicology and Chemistry that the chemical content in single-use Puff EC was high and had cytotoxicity or toxicity to living cells.


Our data supports the need to regulate the flavoring chemicals and synthetic cooling agents in Puff EC to limit their potentially harmful effects on health," said Esther Omaiye, a former graduate student in the Environmental Toxicology Graduate Program and first author of the research paper. "The levels of nicotine, flavoring chemicals, and synthetic cooling agents in Puff EC are higher than those found in other consumer products, raising concerns about the safety of Puff products.


Omaiye, a postdoctoral researcher in the Prue Talbot laboratory, stated that one of the areas of regulatory concern related to e-cigarettes is the continuous development of novel chemicals in e-liquids.


For many years, we have been aware that EC design has been continuously evolving," said Talbot, the professor of cell biology leading the research team.


Recently, it has been discovered that chemicals used in e-cigarette liquids are changing. These changes are often made to make e-cigarette products more appealing to teenagers or to avoid regulation by the FDA, such as using synthetic nicotine instead of tobacco-derived nicotine to avoid FDA restrictions.


According to Talbot, the synthetic cooling agent WS-23, developed for use in shaving cream, is now included in EC liquids, but there is little information available about its inhalation toxicity.


Our work indicates that the concentration of WS-23 used in Puff ECs is sufficient to have negative long-term health effects," she said.


Other findings of the study include:


The EC in Puff contains a much higher concentration of synthetic cooling agents and flavor chemicals than JUUL EC.


Despite the unknown risks of inhaling, EC manufacturers are increasing the use and concentration of synthetic cooling agents, which is appealing to young users.


This article is compiled from third-party information and is intended only for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truth or accuracy of its contents. The compilation of this article is solely for industry exchange and research purposes.


Due to limitations in translation abilities, the compiled article may not fully express or accurately reflect the original text. Please refer to the original text for accuracy.


Regarding any domestic, Hong Kong, Macao, Taiwan, or international related statements and positions, 2FIRSTS fully aligns with the Chinese government.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to request removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

 Correction and Apology Regarding Two Erroneous Reports
Correction and Apology Regarding Two Erroneous Reports
Jun.27
Bangladesh Supreme Court Rejects Lease Appeal, British American Tobacco to Close Dhaka Factory
Bangladesh Supreme Court Rejects Lease Appeal, British American Tobacco to Close Dhaka Factory
British American Tobacco Bangladesh (BAT) will relocate its headquarters from Mohakhali to Ashulia in mid-2025 after the Supreme Court rejected its appeal to extend the Dhaka camp land lease. The move includes the closure of the 61-year-old Dhaka factory. BAT plans a smooth transition and reported a strong Q1 2025 performance of BDT 95.97 billion ($800 million).
Jun.23 by 2FIRSTS.ai
UK Bans Disposable E-Cigarettes, Market Shifts to Reusable Alternatives
UK Bans Disposable E-Cigarettes, Market Shifts to Reusable Alternatives
Starting June 1, the UK officially implemented its disposable e-cigarette ban, prohibiting the sale of non-refillable and non-rechargeable products. According to the Financial Times, several major brands have quickly released reusable versions with similar designs, raising concerns among experts about the effectiveness of the policy.
Jun.03 by 2FIRSTS.ai
FDA Appoints Bret Koplow as Acting Director of CTP
FDA Appoints Bret Koplow as Acting Director of CTP
According to the U.S. Food and Drug Administration’s website, Bret Koplow has been appointed acting director of the Center for Tobacco Products (CTP). Koplow has been with the FDA since 2011, holding several key roles, most recently serving as senior advisor to the FDA Commissioner.
May.21 by 2FIRSTS.ai
2Firsts Convenes 2025 Insight Forum on Dual Challenges of U.S. NGP Regulation & Tariff Trends/ Closed-Door Forum on Nicotine Pouch PMTA Technical Analysis
2Firsts Convenes 2025 Insight Forum on Dual Challenges of U.S. NGP Regulation & Tariff Trends/ Closed-Door Forum on Nicotine Pouch PMTA Technical Analysis
2Firsts hosted a seminar in Shenzhen on 2025 Insight Forum on Dual Challenges of U.S. NGP Regulation & Tariff Trends/ Closed-Door Forum on Nicotine Pouch PMTA Technical Analysis. Experts from CSUR provided in-depth analysis of compliance pathways, aiming to help the industry navigate dual challenges of regulation and tariffs.
May.16 by 2FIRSTS.ai
PMI Launches "Invest in America" Campaign as ZYN Factory Set for Full Operation in 2026
PMI Launches "Invest in America" Campaign as ZYN Factory Set for Full Operation in 2026
PMI US has launched the “Invested in America” campaign to spotlight its $600 million investment in a new ZYN nicotine pouch facility in Arizona, projected to create 500 direct and 1,000 indirect jobs.
Jul.04 by 2FIRSTS.ai